Efficacy of Nylidrin Hydrochloride in the Treatment of Cognitive Impairment in the Elderly*
- 1 May 1979
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 27 (5) , 235-236
- https://doi.org/10.1111/j.1532-5415.1979.tb06039.x
Abstract
A double-blind study was conducted on the effects of nylidrin hydrochloride [NH] vs. placebo in 60 patients with mild to moderate symptoms of chronic brain syndrome. Their ages ranged from 65-99 yr. NH (a vasodilator) is a relatively safe therapeutic agent and more effective than placebo in ameliorating the symptoms of cognitive impairment associated with aging, on both a short-term (3 mo.) and a long-term (9 mo.) basis. In a dosage of 24 mg daily it reached its peak effectiveness after 3 mo. of use.This publication has 5 references indexed in Scilit:
- Cyclandelate in the Treatment of Senile Mental Changes: A Double‐Blind EvaluationJournal of the American Geriatrics Society, 1977
- Effects of Chronic Papaverine Administration on Mild Senile Organic Brain SyndromeJournal of the American Geriatrics Society, 1977
- An Ergot Alkaloid Preparation (Hydergine) in the Treatment of Dementia: Critical Review of the Clinical LiteratureJournal of the American Geriatrics Society, 1976
- Cyclandelate in the Treatment of Cerebral Arteriosclerosis*Journal of the American Geriatrics Society, 1976
- A New Scale for Clinical Assessment in Geriatric Populations: Sandoz Clinical Assessment – Geriatric (SCAG)*Journal of the American Geriatrics Society, 1974